Aprea Therapeutics to Present at DDR Inhibitors Summit 2024

January 30, 2024

https://www.globenewswire.com/news-release/2024/01/30/2819921/0/en/Aprea-Therapeutics-to-Present-at-DDR-Inhibitors-Summit-2024.html

DOYLESTOWN, Pa., Jan. 30, 2024 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq:APRE) (“Aprea”, or the “Company”), a clinical stage biopharmaceutical company focused on precision oncology through synthetic lethality, today announced that Dr. Oren Gilad, President and CEO, will deliver a presentation at the 7th DDR Inhibitors Summit, to take place January 30 to February 1, 2024 in Boston, MA.

Read more at globenewswire.com

Related news for (APRE)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.